When DAA Treatment for Hepatitis C Fails, 3-Drug Regimen " Highly Effective " (FREE)

By Kelly Young Edited by Susan Sadoughi, MD, and Richard Saitz, MD, MPH, FACP, DFASAM The combination of sofosbuvir, velpatasvir, and voxilaprevir is effective for hepatitis C in patients with virologic failure after direct-acting antiviral agent (DAA) treatment, according to two phase 3, industry-funded trials in the …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news